BDBM284415 4-(6-(4-(4- chlorobenzyl)piperazin-l- yl)pyridin-3-yl)-6-(1- methyl-1H-pyrazol-4- yl)pyrazolo[1,5-a]pyridine- 3-carbonitrile::US10023570, Example 425::US10174028, Example 425

SMILES Cn1cc(cn1)-c1cc(-c2ccc(nc2)N2CCN(Cc3ccc(Cl)cc3)CC2)c2c(cnn2c1)C#N

InChI Key InChIKey=RPWABDWRYSLHIF-UHFFFAOYSA-N

Data  6 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 284415   

TargetProto-oncogene tyrosine-protein kinase receptor Ret [658-1114](Homo sapiens (Human))
Array Biopharma

US Patent
LigandPNGBDBM284415(4-(6-(4-(4- chlorobenzyl)piperazin-l- yl)pyridin-3...)
Affinity DataIC50:  25.6nMpH: 7.4Assay Description:Compounds of General Formula I were screened for their ability to inhibit wild type and V804M mutant RET kinase using CisBio's HTRF® KinEASE -TK ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent